Stock results analysis for Industry - Biotechnology for Q1 FY25-26 ending Jun 30, 2025

Analysis of which stocks have performed the best and worst in Industry - Biotechnology for Q1 FY25-26 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current quarter are considered.

Stock universe
5
POSITIVE PROFIT GROWTH
4
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
14.6 %
TOTAL REVENUE GROWTH
-48.3 %
TOTAL EBIDT GROWTH
17.2 %
TOTAL OPER. PROFIT GROWTH
 Positive  Negative  Pending
Stock Last Result Updated Market Capitalization Current Price Operating Revenue Qtr Revenue Growth Qtr YoY % Revenue Surprise Qtr % Net Profit Qtr Net Profit Qtr Growth YoY % Net Profit Surprise Qtr % Operating Profit Qtr Operating Profit Growth Qtr YoY % EBITDA Qtr EBITDA Qtr growth YoY % Operating Profit Margin Qtr % Operating Profit Qtr Margin% YoY Change
Alpa Laboratories 13-Aug-2025 198.60 94.39 - -
Biocon 07-Aug-2025 47375.31 354.35 -1.03 -69.34
Panacea Biotec 14-Aug-2025 2813.86 459.40 - -
Vivo Bio Tech 12-Aug-2025 63.22 39.20 - -
Genesis IBRC 14-Aug-2025 69.54 53.49 - -
Genomic Valley Biotech 08-Aug-2025 11.36 37.18 - -
Shree Ganesh Bio-Tech 25-Jul-2025 31.49 0.79 - -
Advanced Enzyme 02-Aug-2025 3804.52 340.05 - -
Concord Biotech 08-Aug-2025 17109.98 1635.50 -13.84 -32.37